Early Diagnosis and Treatment of Mild Cognitive Impairment / Edition 1

Hardcover (Print)
Buy New
Buy New from BN.com
$79.26
Used and New from Other Sellers
Used and New from Other Sellers
from $39.01
Usually ships in 1-2 business days
(Save 56%)
Other sellers (Hardcover)
  • All (6) from $39.01   
  • New (3) from $65.95   
  • Used (3) from $39.01   

Overview

Written by leading authorities in the field, this book describes the cognitive changes associated with age, the earliest detectable stages of Alzheimer’s, and the relationship of these conditions to MCI. The authors review the latest advances in our understanding of MCI, its prevalence, evaluation, management, and outcomes and in so doing provide practising physicians with a useful resource that assists them in identifying those MCI patients who will progress to recognised Alzheimer’s Disease.

Beautifully presented in full colour, Early Diagnosis and Treatment of Mild Cognitive Impairment includes case studies and discusses future therapeutic and diagnostic strategies. It is an invaluable resource for postgraduates and professionals, for specialist physicians in neurology and psychiatric medicine, geriatric medicine and general practice.

Read More Show Less

Product Details

  • ISBN-13: 9780470319369
  • Publisher: Wiley
  • Publication date: 6/2/2008
  • Edition description: New Edition
  • Edition number: 1
  • Pages: 156
  • Product dimensions: 5.90 (w) x 8.30 (h) x 0.60 (d)

Meet the Author

Dr Burns is an Assistant Professor in the Department of Neurology at the University of Kansas Medical Center. He is the Director of the Alzheimer and Memory Center and the Alzheimer’s Disease Clinical Research Program and serves as the Principal Investigator of the Brain Aging Program.

Read More Show Less

Table of Contents

1. Introduction.

What is mild cognitive impairment?

Epidemiological studies of MCI.

The border zone between aging and dementia: cognitive and neuropathological changes.

Aging and cognitive performance.

2. Neuropathology of Alzheimer’s disease, non-demented aging and MCI.

Histopathological features.

Plaques.

Neurofibrillary pathology.

Neuronal loss.

Topography of neuropathological changes.

Neuropathological AD diagnosis.

Neuropathology of aging.

Neuropathology of MCI.

Does a subset of MCI patients actually have early Alzheimer’s disease?

Clinical studies.

Neuroimaging.

3. Detecting and diagnosing MCI and early AD.

Early detection.

Recognition of MCI and early AD.

Informant-based history.

Neurological examination.

Laboratory and radiological evaluation.

Psychometric/mental status testing.

Dementia-screening instruments.

Mini-mental state examination.

Clock-drawing test.

Seven-minute screen.

Dementia staging instruments.

CDR.

Global deterioration scale.

4. Etiology of MCI: differential diagnosis.

“Worried-well”.

Depression.

Other etiologies.

Neurodegenerative dementias.

Overlap disorders.

Dementia with Lewy bodies.

Vascular dementia.

Frontotemporal lobar dementias.

Identifying the subset of MCI that is AD.

5. Treatment of MCI and dementia.

MCI.

The case for early treatment.

Non-pharmacological treatment.

Dementia therapy.

Approved therapies.

Cholinergic hypothesis.

Cholinesterase inhibitors.

Donepezil.

Rivastigmine.

Galantamine.

Memantine.

Agents under investigation for AD treatment and prevention.

Vitamin E and selegiline.

Estrogen.

Anti-inflammatory agents.

Cholesterol-reducing agents.

Chelation therapy.

6. Future therapeutic and diagnostic strategies.

Amyloid hypothesis.

Secretase inhibitors.

Amyloid vaccine.

Potential biomarkers.

CSF biomarkers.

CSF amyloid beta (Aβ).

CSF tau.

CSF sulfatide.

CSF markers of inflammation.

CSF markers of oxidative stress.

Serum biomarkers.

Structural imaging.

Functional neuroimaging.

PET and SPECT.

Functional MRI (fMRI).

Imaging amyloid.

Genetic testing.

Early-onset familial AD.

Amyloid precursor protein.

Presenilin genes.

Late-onset AD.

Apolipoprotein E.

7. Case studies.

Case report 1: MCI as early-stage Alzheimer’s disease.

Comment.

Case report 2: Diagnosis of dementia prior to impairment sufficient for MCI.

Comment.

Case report 3: Memory complaints associated with non-demented aging.

Comment.

References.

Index.

Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)